Economic Opportunity: Brand Drugs vs. Generic Drugs
| المؤلف | Al-Badriyeh, Daoud |
| تاريخ الإتاحة | 2018-05-20T07:57:24Z |
| تاريخ النشر | 2018-03-10 |
| اسم المنشور | Conference: Medication sector in Qatar: Hand in Hand Facing the blockade |
| الاقتباس | Al-Badriyeh, Daoud. Economic Opportunity: Brand Drugs vs. Generic Drugs. Conference: Medication sector in Qatar: Hand in Hand Facing the blockade. Pharmacy collage, Qatar university. 10 March 2018. |
| الملخص | Outlines: * Pharmaceutical markets in the Middle East region are attractive *The high spending on branded drugs is unsustainable *Publicly funded health systems – increased pressure to reduce rising drug budgets *Originator (NDA) vs Generic (ANDA) review process requirements 20-90% cheaper generics * The generic drug industry is responsible for making more affordable and cost-saving medicines |
| اللغة | en |
| الموضوع | Medicine Sector - Qatar Blockade حصار قطر- القطاع الدوائي Qatar Blockade - Blockade Countries – Medicine Brand drugs - Generic drugs - Qatar Blockade |
| النوع | Presentation |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
الندوات والحوارات [57 items ]
-
Medication sector in Qatar: Hand in Hand Facing the blockade (9 – 10 March 2018) [13 items ]
-
أبحاث الصيدلة [1314 items ]